Both TMS and Spravato (esketamine nasal spray) have FDA approval specifically for treatment-resistant depression. They take very different paths — brain stimulation versus rapid-acting pharmacology — and the day-to-day experience is nothing alike.
What You’ll Learn
- How the mechanisms differ
- Speed of response comparison
- Treatment schedule and session requirements
- Side effects comparison
- Cost and insurance differences
Mechanism of Action
TMS: Magnetic pulses stimulate the left DLPFC, gradually restoring normal activity in mood circuits over weeks of treatment. The effects build through cumulative neuroplastic changes.
Spravato: Esketamine blocks NMDA glutamate receptors, triggering rapid synaptic plasticity and new neural connections. It’s derived from ketamine and works through an entirely different pathway than traditional antidepressants.
Efficacy Comparison
| Outcome | TMS | Spravato |
|---|---|---|
| Response rate | 50-60% | 50-70% |
| Remission rate | 30-35% | 25-35% |
| Speed of response | 2-4 weeks | Days to 1-2 weeks |
| Maintenance needed | Maybe (6-12 months) | Yes (ongoing) |
Treatment Experience
TMS sessions:
- 36 sessions over 6-9 weeks (weekdays)
- 19-37 minutes per session
- Sit in a chair, fully alert, no sedation
- Drive yourself to and from the clinic
- Go right back to work after
Spravato sessions:
- Twice weekly for 4 weeks, then weekly, then every 1-2 weeks — indefinitely
- Self-administer the nasal spray at a certified clinic
- 2-hour mandatory monitoring period after each dose
- Can’t drive for the rest of the day
- Must take with an oral antidepressant (always add-on, never standalone)
Side Effects
TMS: Scalp discomfort, mild headache. No systemic effects. No sedation. No driving restrictions.
Spravato: Dissociation (feeling detached from reality), dizziness, nausea, sedation, increased blood pressure, anxiety. These effects usually clear within 2 hours — which is why you’re monitored at a certified REMS clinic.
Insurance and Cost
TMS:
- Widely covered after 2+ medication failures
- $200-$400/session; $6,000-$12,000 total course
- Treatment ends after 6-9 weeks (may need retreatment in 6-12 months)
Spravato:
- FDA-approved — covered by most insurers with prior auth
- $600-$900 per session before insurance
- Ongoing indefinitely — the annual costs add up
- Must always be paired with an oral antidepressant
Key Decision Factors
Choose TMS if:
- You want a time-limited treatment (done in 6-9 weeks)
- You need to drive and work on treatment days
- You’d rather skip sedation and dissociative effects
- You prefer not to be on ongoing medication
Choose Spravato if:
- You need the fastest possible response (days, not weeks)
- You’re fine with ongoing maintenance sessions
- The 2-hour monitoring requirement works for your schedule
- You’re already on an antidepressant you want to keep taking
Search for TMS providers or explore other device comparisons.
Key Takeaways
- TMS is time-limited (6-9 weeks); Spravato requires ongoing maintenance
- Spravato works faster (days) than TMS (weeks)
- TMS requires no sedation; Spravato causes dissociation requiring monitoring
- Both are FDA-approved and insurance-covered for TRD
- Some patients benefit from combining both treatments
Find a TMS Clinic
Browse verified TMS providers, compare clinics, and find the right treatment for your situation.